Core Insights - Streamex Corp. is hosting a corporate update webinar on December 16, 2025, to review its 2025 achievements, provide an update on the GLDY launch, and outline its strategic roadmap for 2026 and beyond [1][2] 2025 Strategic Achievements - The company has expanded its leadership and advisory network with seasoned industry executives to enhance its capabilities [3] - Streamex has strengthened its capital position, entering 2026 with a well-capitalized balance sheet, enabling long-term growth [4] Key Personnel and Partnerships - Notable strategic advisors include Frank Giustra and Sean Roosen, with a strong team including Chief Investment Officer Mitch Williams and General Counsel Michael Frisch [5] - The company has established partnerships with Monetary Metals for yield-bearing precious metals, Simplify Asset Management for ETF integration, and Chainlink for GLDY's Proof of Reserves [5] GLDY Launch Details - The GLDY pre-sale began on November 10, 2025, with an initial issuance goal of $100 million, expandable to $300 million, and an anticipated launch in Q1 2026 [8] - Each GLDY token represents one fine troy ounce of physical gold, accruing yield at up to 4% annualized, with a minimum investment of $200,000 for individuals and $1 million for institutions [9][10] Strategic Roadmap for 2026 and Beyond - Streamex aims to unlock the potential of commodity assets through tokenization, transforming static holdings into yield-generating financial instruments [11] - Planned product launches include silver with yield in 2026, royalties and streams in 2026, copper with yield in 2027, and oil & gas with yield in 2027-2028 [14] Future Tokenization Initiatives - The company plans to expand its real-world asset tokenization platform, with a focus on economically accretive products aligned with its tokenization philosophy [15]

Core Viewpoint - Glen Burnie Bancorp has announced the voluntary delisting of its common stock from Nasdaq and the subsequent deregistration with the SEC to relieve itself of reporting obligations under the Exchange Act [1][5]. Delisting and Deregistration Process - The board has approved the delisting, with a Form 25 to be filed with the SEC around December 22, 2025, and the delisting expected to take effect on January 1, 2026 [2][4]. - Following the delisting, Bancorp plans to file a Form 15 with the SEC on or about January 2, 2026, certifying it has fewer than 1,200 shareholders, which will suspend its reporting obligations [4]. Rationale for Delisting - The decision is based on several factors, including anticipated non-compliance with Nasdaq's listing requirements, lack of research coverage, absence of an active trading market, and the desire to eliminate significant costs associated with being a public company [5]. - The board believes that delisting will allow Bancorp to redirect financial and management resources to a broader range of business opportunities [5]. Future Trading Plans - After delisting, Bancorp intends to have its common stock traded on the OTCQX platform and will continue to provide information to stockholders [3]. - There is no guarantee that trading will continue on the OTCQX or that brokers will provide quotes for its common stock [3]. Company Background - Glen Burnie Bancorp is a bank holding company based in Glen Burnie, Maryland, operating The Bank of Glen Burnie, which offers commercial and retail banking services [7].

Core Viewpoint - Pasinex Resources Limited has secured 100% ownership of Horzum Arama ve Madencilik AŞ, enabling full control over the high-grade Pinargözü zinc mine in Türkiye, with plans to expand production and explore deeper mineralization [1][2][4]. Group 1: Ownership and Corporate Structure - Türkiye's General Directorate of Mining and Petroleum Affairs (MAPEG) has approved the transfer of shares in Horzum AS to Pasinex Arama, completing the ownership transition [1][2]. - Final corporate registration procedures for the ownership transfer are expected to be completed by December 31, 2025 [2]. Group 2: Development and Exploration Plans - A comprehensive development plan has been finalized to expand production capacity and access deeper high-grade mineralization at the Pinargözü mine [3]. - The upcoming program will focus on two primary exploration opportunities, targeting geological potential and continuity of high-grade zinc mineralization [3][8]. Group 3: Management Insights - The Executive Chairman of Pasinex emphasized that the MAPEG approval is a transformative milestone, allowing the company to unlock the mine's deeper potential [4]. - A new 1,000-metre adit will be developed to access identified high-grade sulphide zones and prospective marble-altered zones, enhancing discovery potential [4][7]. Group 4: Workforce and Infrastructure Development - Recruitment of additional technical staff and underground personnel has commenced to support increased mining activities [7]. - The 1,000-metre development project is set to begin in early January 2026, including a 700-metre decline to access lower levels and additional infrastructure for ventilation and drilling [7]. Group 5: Mineralization and Resource Expansion - Drilling has intersected high-grade zinc sulphide mineralization, including 1.5 metres of material with 43% zinc at the 425-metre level, indicating significant potential for resource expansion [8]. - Numerous secondary high-grade zinc veins have been identified, with plans for a dedicated drilling campaign to evaluate their continuity and expand the resource inventory [8]. Group 6: Company Overview - Pasinex Resources Limited is a zinc-focused mining company based in Toronto, Canada, with 100% ownership of Horzum AS, which operates the Pinargözü high-grade zinc mine [11]. - The company also holds a 100% interest in the Sarıkaya Group IV lead-zinc operating license and a 51% interest in the Gunman Project in Nevada, indicating further growth potential [12].

Core Insights - Serve Robotics has achieved its 2025 goal of deploying over 2,000 delivery robots, establishing the largest sidewalk delivery fleet in the U.S. [1][15] - The company has expanded its fleet twentyfold within a year, driven by partnerships with major restaurants, retailers, and delivery platforms like Uber Eats and DoorDash [2][4]. Company Growth and Market Expansion - Serve Robotics has rapidly expanded across key U.S. markets, including Los Angeles, Atlanta, Dallas-Fort Worth, Miami, Fort Lauderdale, Chicago, and Alexandria, with plans to launch in additional cities in early 2026 [2][4]. - In 2025, the company expanded service zones in all existing markets, launched in 110 high-density neighborhoods, and introduced Gen 3 robots for higher-volume operations [5]. Technology and Environmental Impact - The robotic fleet operates with Level 4 autonomy, achieving a 99.8% completion rate in complex urban environments, and produces zero tailpipe emissions [3][5]. - Serve Robotics aims to reduce congestion and carbon output in partner cities by replacing traditional delivery vehicle trips with its autonomous robots [3]. Future Opportunities - The market opportunity for autonomous sidewalk delivery is significant, with potential applications in groceries, convenience items, small parcels, and return logistics [5]. - The company anticipates that its robots will become a common part of local logistics over the next five years, enhancing delivery efficiency for various types of goods [5].

Core Insights - Abaxx Technologies Inc. has launched the Enwex U.K. Onshore Wind (UWM) futures, marking the second contract in its weather derivatives suite, aimed at managing wind-generation variability in the U.K. market [1][2] - The U.K. contract is the first exchange-listed benchmark for U.K. wind generation, addressing the unique risk profile of a wind-dependent power market influenced by Atlantic weather patterns [2][4] - The contract is denominated in pound sterling and is indexed to a forecast-based index that translates wind speed into standardized generation utilization rates, expressed in £/MWh [3] Company Overview - Abaxx Technologies is focused on building smarter markets through improved tools, benchmarks, and technology to address societal challenges, including the energy transition [5] - The company is the majority shareholder of Abaxx Singapore Pte. Ltd., which owns the Abaxx Exchange and Abaxx Clearing, and is involved in developing digital market infrastructure [6][7] - Abaxx Exchange aims to facilitate the shift towards a low-carbon economy by providing centrally-cleared, physically-deliverable futures contracts across various commodities [7] Market Impact - The introduction of the U.K. wind futures is seen as a significant step towards increasing market accessibility and reflects Abaxx's commitment to developing weather markets [4][2] - The contract allows for the transfer of volumetric risk from renewable generation into exchange-traded products, enhancing market pricing and management capabilities [4][2] - The trading hours for the Enwex U.K. Onshore Wind futures are set from 1000 to 2400 SGT, Monday to Friday, excluding Singapore public holidays [4]

TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) announces that it has now completed exploration diamond drilling on the Lutila Gold Project located in Central Slovakia. The Lutila exploration licence covers an area of 32.2km² and is prospective for quartz-adularia, low-sulfidation epithermal gold mineralisation. The Company completed two diamond drill holes as part of its exploration programme. One hole was drilled into the Horna Klapa target area which is l ...

Core Insights - Zelluna has successfully manufactured and quality controlled the first GMP batch of its lead candidate, ZI-MA4-1, intended for its first-in-human clinical trial, marking a significant milestone in the company's development process [1][4] - The proprietary manufacturing process allows for the generation of hundreds of doses from a single run, enhancing patient access and reducing costs [2][5] - ZI-MA4-1 is the first MAGE-A4-targeting TCR-NK therapy, designed to address challenges in treating solid tumors, including tumor heterogeneity and antigen loss, while maintaining a favorable safety profile [3][4] Company Overview - Zelluna ASA is a biotechnology company focused on developing allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for cancer treatment [5] - The company aims to combine the innate killing power of NK cells with the precision targeting of TCRs to overcome limitations of current therapies, particularly in solid tumors [5] - Zelluna plans to submit a Clinical Trial Application (CTA) for ZI-MA4-1 in the second half of 2025, with initial clinical data expected by mid-2026 [4][6]

Core Insights - GXO Logistics, Inc. has appointed Bart Beeks as the new Chief Operating Officer (COO), effective January 2, 2026, to enhance global operational excellence [1][5] - The appointment aims to improve productivity, efficiency, and customer value through standardized global execution [2] Company Overview - GXO Logistics is the world's largest pure-play contract logistics provider, with over 150,000 team members and more than 1,000 facilities totaling over 200 million square feet [3] - The company focuses on addressing complex logistics challenges for leading blue-chip companies, leveraging advanced supply chain and e-commerce solutions [3]

Core Insights - Castle Biosciences, Inc. announced a systematic review and meta-analysis demonstrating that the TissueCypher® Barrett's Esophagus test provides clinically validated risk stratification for patients with Barrett's esophagus, outperforming traditional pathology or clinical factors in identifying patients at increased risk of developing esophageal cancer [1][2]. Group 1: Study Findings - The systematic review and meta-analysis consolidated data from six studies, confirming that TissueCypher consistently identifies patients at greater risk of progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) [2]. - The study represents the most comprehensive validation of the TissueCypher test to date, reinforcing its value as an evidence-based tool for risk stratification in Barrett's esophagus [3][5]. - TissueCypher has been shown to be the strongest independent predictor of progression compared to traditional histopathological risk assessment, with high-risk results indicating patients are 6.7 times more likely to progress to HGD or EAC within five years than those with low-risk results [7][9]. Group 2: Clinical Implications - The findings support personalized, risk-aligned patient management aimed at preventing cancer, allowing physicians to identify which patients may benefit from earlier intervention and those who can continue routine surveillance [3][5]. - Patients with high or intermediate-risk results had an annual progression rate of 2.8%, while those with high-risk results had a rate of 5.6% per year, both exceeding the typical 1.7% annual progression rate for patients with low-grade dysplasia [9]. Group 3: Test Overview - TissueCypher is a precision medicine test designed to predict a patient's personalized risk of progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma, indicated for patients with non-dysplastic BE, indefinite for dysplasia, or low-grade dysplasia [6]. - The test utilizes an AI-driven spatialomics approach to identify molecular signatures that precede dysplasia development, enabling earlier identification and management of patients at increased risk of cancer [7].

BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 13, 2026, including a presentation at 10:30am PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com. About Option Care Heal ...